30 WORLD GASTROENTEROLOGY NEWS MAY 2017 Editorial | Expert Point of View | WCOG at ACG 2017 | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events agents to add to our current arma-mentum of Infliximab and Adalim-umab. Professor of Hepatic Medicine, Geoffrey Farrell, from the Australian National University Medical School in Canberra presented the latest infor-mation regarding the lingering effects of alcohol to the liver, the metabolic system and its relation to obesity. An afternoon session in the multi-pronged management of functional GI disorders encompassed: general practice (Dr. Fraser Hamilton), models of care (Prof. Jane Andrews), cognitive behavioral therapy (Meagan Spence) and dietitian aspects (Anna Richards). A session regarding a broad group of liver injury was held. Topics reviewed included: difficult cases of autoimmune liver disease (Dr. Rachael Harry), drug induced liver disease (Prof. Catherine Stedman) and lipo-toxic pathogenesis of NASH (Prof. Geoffrey Farrell). Visiting speaker Dr. Bertus Eksteen, Clinical Associ-ate Professor in Medicine from the University of Calgary, discussed new research in PSC and IgG4 disease. Nursing aspects in the care of IBD and IBS were reviewed in a parallel session. Invited international Nurse Practioner Joan Heatherington from the University of Calgary IBD clinic reviewed multidisciplinary team man-agement of IBD. Other topics included: breath test-ing (Sarah Silvester and Lizze Bill-mans), visceral hypersensitivity (Dr. Liz Phillips) and adherence support (Brenda Cross). Further afternoon sessions included presentations of foregut diseases. Professor Michael Camilleri presented case-based discus-sion of Foregut syndrome. Professor John Windsor discussed new founda-tions for treating functional upper GI disorder. Dr. Stephen Burmeister updated us on the Chicago V3 clas-sification of esophageal disorders. A concurrent session regarding the com-plications “Bogan-Zombie Apocalypse” dinner, A/Prof Michael Schultz, President of NZSG and Dr. Russell Walmsley, Immediate Past President, NZSG of cirrhosis was held. Dr. Dara de Las Heras discussed ascites and hepatorenal syndrome. Dr. Frank Weilert covered varices and Dr. Ra-chael Harry updated encephalopathy. Lively parallel dinner sessions cov-ered: IBD topics (Prof. Jane Andrews, Prof. Richard Gearry, Dr. Melissa Haines, Dr. Stephen Inns) and viral hepatitis topics (Prof. Catherine Sted-man, Dr. Dominic Ray-Chaudhuri, Dr. Stephen Gerred). Thursday morning saw luminal free papers and pancreatobiliary sessions. In the free papers Dr. Catherine Wall looked at fecal biomarkers and ac-tive Crohn’s disease. Dr. Ming Han Lim presented on the endoscopic management of large sessile high grade polyps. This was subsequently awarded best registrar presentation. Dr. Ho Nam Lee compared acute with chronic iron deficiency anemia in colonic neoplasms. This research was awarded the best young investiga-tor - luminal. Dr. Jim Brooker presented the early New Zealand experience of POEM (peroral endoscopic myotomy). Dr. Siva Pulusu presented findings of ser-rated polyposis syndrome cohort and interval cancers. Dr. Aditya Sheth pre-sented findings of radiation exposure to staff and patients during ERCP. Dr. James Fulforth examined the utility of methane breath testing in IBS. In the pancreatobiliary interven-tion session visiting speaker Associate Professor Ian Norton from the Royal Prince Alfred and Concorde Hos-pitals in Sydney presented strategy after ERCP failure. Dr. Estella Johns presented on the management of gastric outlet obstruction. Dr. Russell Walmsley presented on celiac plexus neurolysis. Dr. Nick Burgess present-ed on the locoregional interventions in pancreatic cancer. Further free papers were presented. Dr. John Lubel presented results of Viekira therapy in cirrhosis. Dr. Helen Myint was awarded the prize for best research–liver for the paper “Probi-otic supplementation after a very low calorie diet does not aid improve-ment of the metabolic syndrome or maintenance of weight loss post liver transplant: A randomized double-blind placebo controlled trial”. Dr. Sebastiaan ten Bokkel Huinink
ewgn-vol22-issue1-v11
To see the actual publication please follow the link above